跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Betazak-8 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Betazak-8
Approved
STANDARD
Betazak-8
Schazoo Zaka (Pvt.) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
de22a85bd54b4e79
Company
Schazoo Zaka (Pvt.) Ltd.
Type
Standard
Approval Details
Approval Id
de22a85bd54b4e79
Drug Approval Philippines Name
Betazak-8
Product Name
Betazak-8
Registration Number
DRP-15809
Brand Name
Betazak-8
Generic Name
Betahistine (as hydrochloride)
Dosage Form
Tablet
Dosage Strength
8 mg
Manufacturer
Schazoo Zaka (Pvt.) Ltd.
Issuance Date
23 September 2024
Expiry Date
23 September 2029
Pharmacologic Category
Antivertigo preparation
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
de22a85bd54b4e79
Type
Standard
Back to Philippines FDA Approvals